Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Acura Pharmaceuticals Inc
ACUR | US
0.00
USD0.00
300.00%
ACUR | US
About Acura Pharmaceuticals Inc
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/09/2021
As of date
21/04/2026
Close
0.00
Open
0.00
High
0.00
Low
0.00
View Less
ACUR | US
Risk
2579.3
Sharpe
0
Luna's Score
36/100
Recommendation
Sell
Luna says (ACUR | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
2579.3%1 month
2579.3%3 months
2184.6%6 months
1316.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.48
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-4.61
Ent. to rev.
0.14
PEG
-
Other Fundamentals
EBITDA
-1.14M
MarketCap
26.40K
MarketCap(USD)
26.40K
Div. yield
-
Op. margin
-658.33
Erngs. growth
-
Rev. growth
-95.00
Ret. on equity
-
Short ratio
0.73
Short perc.
1.20
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.00
Range1M
0.00
Range3M
0.01
Volumes: Market Activity
Rel. volume
0.40
Price X volume
1.40
